The European Food Safety Authority (EFSA) has reviewed the extensive safety documentation on Pharma Nord's selenium yeast SelenoPrecise and concluded that the product does not present any safety concern.
Once again, Pharma Nord teamed up with the International Coenzyme Q10 Association to present the latest medical sciences about Q10 to a large number of doctors, pharmacists and other health professionals. The congress drew more than 600 visitors from all over the world.
A large number of guests were present to witness the official opening of the new Pharma Nord Education and Research Center in the Czech Republic.
A recently published Cochrane Review of a Danish meta-analysis has prompted news headlines around the world in the direction of "Vitamins may reduce lifespan" and "Certain vitamins could increase mortality".
For the second year in a row, Bio-CLA from Pharma Nord has been chosen as the best product in two different categories by a Polish pharmacy trade magazine.
More than 200 doctors and pharmacy staff were gathered in Tallinn on Friday the 22nd of February to learn about sexual dysfunction and the patented male sexual enhancer Prelox.
For the second year in a row, Pharma Nord's slimming product Bio-T holds the position as the best selling slimming product in the Netherlands.
Pregnant women give birth to bigger and heavier babies when they take supplements of multivitamins and minerals during pregnancy, studies show.
Stress, too much salt and lack of exercise can increase your blood pressure, but now it seems that vitamin D deficiency may have the same effect. Strangely, the phenomenon only seems to occur in Caucasians.
People who take multiple dietary supplements have far better health than those who only take a single multivitamin or no supplements at all.
The preparation Evelle that stimulates biological processes of importance to skin ageing has documented that it blocks wrinkles.
Pharma Nord is currently building a new production plant in Vojens. With their new production and storage facility they will be able to triple their current production capacity, which is necessary in order to meet the increasing demand for Pharma Nord products in Denmark and abroad.